Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Followers

62 Following

Tom Powles (@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

6 months ago

Extended follow up for Enfortumab/pembro in 1st line advanced UC (m 26mnths). PFS and OS HRs 0.48 & 0.51 respectively. Median duration of response is 2 yrs for the 68% who responded. The 30% with CR have75% & 95% 2 year PFS and OS respectively. Overall G3+ AEs 56 vs 57 % #GU25

Extended follow up for Enfortumab/pembro in 1st line advanced UC (m 26mnths). PFS and OS HRs 0.48 & 0.51 respectively. Median duration of response is 2 yrs for the 68% who responded. The 30% with CR have75% & 95% 2 year PFS and OS respectively. Overall G3+ AEs 56 vs 57 % #GU25